Management of Congenital Aniridia
Infants and children with congenital aniridia should be immediately referred to a pediatric ophthalmologist for comprehensive evaluation and lifelong specialized care, with concurrent genetic testing for PAX6 mutations and screening for WAGR syndrome to rule out Wilms tumor risk. 1
Initial Evaluation and Referral
The American Academy of Pediatrics explicitly mandates referral to a pediatric ophthalmologist for all infants and children with congenital or genetic ocular anomalies, specifically naming aniridia 1. This referral should occur immediately upon diagnosis or suspicion, as aniridia is a progressive panocular disease requiring specialized expertise beyond general ophthalmology.
Genetic Evaluation
Genetic testing for PAX6 mutations must be performed in all cases of congenital aniridia 2, 3, 4. Approximately two-thirds of cases are familial with autosomal dominant inheritance, while one-third are sporadic 2. The genetic workup should include:
- PAX6 gene sequencing as the primary test (responsible for classic aniridia in most cases)
- Chromosomal microarray or karyotype to detect 11p13 deletions associated with WAGR syndrome (Wilms tumor, Aniridia, Genitourinary abnormalities, intellectual disability/Range of developmental delays) 2, 5
- Next-generation sequencing panels if PAX6 is negative, as other genes (FOXC1, PITX2, CYP1B1, FOXD3, TRIM44) can cause aniridia-like phenotypes 3, 6
Referral to a clinical geneticist is essential for comprehensive genetic counseling, family screening, and management of syndromic associations 7.
Systemic Screening for WAGR Syndrome
All patients with sporadic aniridia or those with 11p13 deletions require immediate screening for Wilms tumor, which carries a 45-60% lifetime risk in WAGR syndrome 2, 5. This surveillance protocol includes:
- Renal ultrasound every 3 months until age 5 years, then every 6 months until age 8 years
- Urinalysis for hematuria
- Blood pressure monitoring
- Evaluation for genitourinary abnormalities
- Assessment for developmental delays and intellectual disability
This requires coordination with pediatric nephrology and oncology specialists 5.
Ophthalmologic Management
Baseline Comprehensive Eye Examination
The initial pediatric ophthalmology evaluation must document:
- Degree of iris hypoplasia (complete vs. partial)
- Foveal hypoplasia severity (the primary determinant of visual prognosis, more significant than iris absence) 3, 4
- Corneal status for early aniridia-associated keratopathy (AAK)
- Intraocular pressure to establish baseline for glaucoma surveillance
- Lens clarity for cataract development
- Optic nerve assessment for hypoplasia
- Nystagmus characteristics
- Visual acuity (age-appropriate testing)
Ongoing Surveillance Schedule
Annual ophthalmologic follow-up is mandatory at minimum 2, with more frequent monitoring based on complications:
- Every 3-6 months for patients developing glaucoma or progressive AAK
- Immediate evaluation for acute symptoms (pain, redness, vision changes)
Progressive Complications Requiring Intervention
Aniridia-associated keratopathy (AAK) develops in most patients and progresses with age, requiring:
- Aggressive lubrication and surface management
- Limbal stem cell deficiency treatment
- Consideration for corneal transplantation with stem cell therapy in advanced cases 4, 8
Glaucoma occurs in 50-75% of patients and is notoriously difficult to manage:
- Medical therapy is often insufficient 5
- Surgical intervention (trabeculectomy-trabeculotomy or glaucoma drainage devices) is typically required 5
- Multiple procedures are frequently necessary due to scarring risk
Cataract management requires careful surgical planning with consideration for iris prosthesis implantation 9, 8.
Multidisciplinary Team Composition
Beyond ophthalmology and genetics, the care team should include 2:
- Low vision specialist for visual rehabilitation
- Occupational therapy for activities of daily living adaptation
- Educational support services for learning accommodations
- Pediatric endocrinology (PAX6 is expressed in pancreas; diabetes risk exists) 2
- Pediatric nephrology/oncology (if WAGR syndrome)
- Developmental pediatrics (if developmental delays present)
- Psychology/social work for coping with chronic visual disability
Disability and Rehabilitation Services
Visual impairment from aniridia causes significant disability affecting mobility, communication, learning, and autonomy 2. Early intervention services and disability rehabilitation must be implemented proactively, coordinated through appropriate disability services agencies to prevent handicap in daily activities 2.
Family Screening
First-degree relatives of patients with confirmed PAX6 mutations should undergo ophthalmologic screening to identify asymptomatic or mildly affected family members, given the autosomal dominant inheritance pattern with variable expressivity 2, 3.
Key Clinical Pitfalls
- Do not assume isolated aniridia—always screen for WAGR syndrome in sporadic cases
- Do not delay genetic testing—molecular diagnosis guides prognosis, family counseling, and eligibility for emerging gene therapies
- Do not underestimate glaucoma risk—it develops insidiously and requires aggressive monitoring
- Do not focus solely on iris absence—foveal hypoplasia is the primary visual limitation and cannot be surgically corrected 3